1. A case of pediatric psoriasis successfully and rapidly treated with ixekizumab.
- Author
-
Megna, Matteo, Fornaro, Luigi, De Lucia, Mario, Rescigno, Orsola, Camela, Elisa, and Fabbrocini, Gabriella
- Subjects
PSORIATIC arthritis ,TREATMENT effectiveness ,PSORIASIS ,INFLAMMATORY bowel diseases ,CHILD patients - Abstract
Particularly, conventional systemic treatments are approved only after 18 years of age while phototherapy is time-consuming showing logistic concerns.3 Biologics represent the only officially approved systemic drugs for moderate-to-severe pediatric psoriasis. We observed a complete skin clearance after only 4 weeks of treatment together with a huge improvement in quality of life and skin symptoms (PASI; 0, BSA 0%, Figure 1C,D); these results were maintained up to the last follow up at 24 weeks of treatment. His failed treatment history was wide: topical agents (0.05% clobetasol propionate), 16 weeks of oral cyclosporine (2.5 mg/kg/day) at the age of 9 years and 24 weeks of nb-UVB therapy when he was 10 years. [Extracted from the article]
- Published
- 2021
- Full Text
- View/download PDF